Variant sequences: the new frontier in sequence IP

A variant sequence is typically a naturally-occurring molecule, most frequently protein, which has been modified in order to impart desired characteristics such as improved stability under anticipated use conditions, or increased activity. Optimising sequences and, of course, the associated IP rights, span most areas of biotechnology.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Careers

Benesch adds former McDermott IP practice head

21 September 2026 The hire brings more than three decades of experience across patent litigation, prosecution, licensing and cross-border matters, advising clients in the medical devices, automotive, manufacturing, consumer products, software and electronics sectors.

Careers

Leading European patent litigator to join Carpmaels & Ransford

18 September 2026 The new hire brings more than two decades’ experience managing complex cross-border disputes in life sciences and technology, including most recently at the Unified Patent Court.

In-house counsel

CIPA Congress: Sustainability is essential for the profession and the planet

18 September 2026 At an event attended by patent experts and judges from Europe, the US and China, delegates gathered in the innovation hub of Manchester, UK, to debate the theme of sustainability "in its broadest sense". Sarah Speight was there to hear ideas spanning the commercialisation of clean tech, to ensuring the patent profession’s resilience in a time of colossal change.

More features

Benesch adds former McDermott IP practice head

Inside the deal boom: LSIPR’s five-part M&A series—all in one place

Beyond the primary patent: How pharma can build competitive barriers

Built to be bought? What makes companies acquisition-ready

J&J names two-decade veteran as chief IP counsel

J&J unit win shuts door on Sandoz generic launch

Abbott clinches 18-country PI in glucose monitoring feud

Italy’s Biofer falls short in Fed Circ appeal over key claim wording

Variant sequences: the new frontier in sequence IP

More on this story

Editor's picks

Editor's picks

More features